These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 2974383

  • 21. Video of dantrolene effectiveness on neuroleptic malignant syndrome associated muscular rigidity and tremor.
    Brvar M, Bunc M.
    Crit Care; 2007; 11(3):415. PubMed ID: 17561987
    [No Abstract] [Full Text] [Related]

  • 22. Neuroleptic malignant syndrome: a review.
    Sewell DD, Jeste DV.
    Yakubutsu Seishin Kodo; 1989 Sep; 9(3):319-33. PubMed ID: 2690542
    [No Abstract] [Full Text] [Related]

  • 23. [Etiologic mechanism of neuroleptic malignant syndrome--hypothesis of dopamine-serotonin imbalance].
    Yamawaki N.
    Seishin Shinkeigaku Zasshi; 1988 Sep; 90(10):869-76. PubMed ID: 3251270
    [No Abstract] [Full Text] [Related]

  • 24. Neuroleptic malignant syndrome.
    Loynes J, Tann S, Redick D, Hickman R.
    Tenn Med; 1999 Oct; 92(10):377, 381. PubMed ID: 10513240
    [No Abstract] [Full Text] [Related]

  • 25. [Dantrolene. Pharmacological and therapeutic aspects].
    Gerbershagen MU, Fiege M, Krause T, Agarwal K, Wappler F.
    Anaesthesist; 2003 Mar; 52(3):238-45. PubMed ID: 12666006
    [Abstract] [Full Text] [Related]

  • 26. [Neuroleptic malignant syndrome].
    Usandizaga I, Pérez de Mendiola MM, Buades J, Martínez J.
    Med Clin (Barc); 1990 Oct 06; 95(11):437. PubMed ID: 2082117
    [No Abstract] [Full Text] [Related]

  • 27. [Neuroleptic malignant syndrome. Case reports].
    Berardi D, Troia M, Veronesi L, Ferrari G.
    Minerva Psichiatr; 1994 Dec 06; 35(4):199-219. PubMed ID: 7861943
    [Abstract] [Full Text] [Related]

  • 28. [Neuroleptic malignant syndrome].
    Nishijima K.
    Ryoikibetsu Shokogun Shirizu; 2003 Dec 06; (38):176-8. PubMed ID: 12876959
    [No Abstract] [Full Text] [Related]

  • 29. [Malignant neuroleptic syndrome].
    Bidzińska E.
    Psychiatr Pol; 1986 Dec 06; 20(6):483-8. PubMed ID: 3299434
    [No Abstract] [Full Text] [Related]

  • 30. [Malignant neuroleptic syndrome. A review of epidemiology, risk factors, diagnosis, differential diagnosis and pathogenesis of MNS].
    Andreassen MD, Pedersen S.
    Ugeskr Laeger; 2000 Mar 06; 162(10):1366-70. PubMed ID: 10745673
    [Abstract] [Full Text] [Related]

  • 31. Dantrolene--a review of its pharmacology, therapeutic use and new developments.
    Krause T, Gerbershagen MU, Fiege M, Weisshorn R, Wappler F.
    Anaesthesia; 2004 Apr 06; 59(4):364-73. PubMed ID: 15023108
    [Abstract] [Full Text] [Related]

  • 32. Successful treatment of a complicated case of neuroleptic malignant syndrome.
    Lappa A, Podestà M, Capelli O, Castagna A, Di Placido G, Alampi D, Semeraro F.
    Intensive Care Med; 2002 Jul 06; 28(7):976-7. PubMed ID: 12122539
    [Abstract] [Full Text] [Related]

  • 33. Cerebral salt-wasting syndrome in a patient with neuroleptic malignant syndrome.
    Lenhard T, Külkens S, Schwab S.
    Arch Neurol; 2007 Jan 06; 64(1):122-5. PubMed ID: 17210819
    [Abstract] [Full Text] [Related]

  • 34. Navigating neuroleptic malignant syndrome.
    Cahill C, Arana GW.
    Am J Nurs; 1986 Jun 06; 86(6):670-3. PubMed ID: 3636063
    [No Abstract] [Full Text] [Related]

  • 35. Management of neuroleptic malignant syndrome--a series of eight cases.
    Kurien T, Rajeev KK, Abraham OC, Archana S, Cherian AM.
    J Assoc Physicians India; 1993 Feb 06; 41(2):91-3. PubMed ID: 8101521
    [Abstract] [Full Text] [Related]

  • 36. Possible central effect of dantrolene sodium in neuroleptic malignant syndrome.
    Yamawaki S, Yanagawa K, Morio M, Mori K.
    J Clin Psychopharmacol; 1986 Dec 06; 6(6):378-9. PubMed ID: 3805336
    [No Abstract] [Full Text] [Related]

  • 37. [Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome: a case report].
    Terlikowska M, Marzański M.
    Psychiatr Pol; 1995 Dec 06; 29(3):343-8. PubMed ID: 7652087
    [Abstract] [Full Text] [Related]

  • 38. Neuroleptic malignant syndrome versus malignant hyperthermia.
    Hard C.
    Am J Med; 1991 Sep 06; 91(3):322-3. PubMed ID: 1892158
    [No Abstract] [Full Text] [Related]

  • 39. Catatonia and neuroleptic malignant syndrome.
    Francis A, Yacoub A.
    Ann Clin Psychiatry; 2008 Sep 06; 20(4):231; author reply 232-3. PubMed ID: 19034757
    [No Abstract] [Full Text] [Related]

  • 40. Therapy of neuroleptic malignant syndrome.
    Lazarus A.
    Psychiatr Dev; 1986 Sep 06; 4(1):19-30. PubMed ID: 3703852
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.